XDNA - Kelly CRISPR & Gene Editing Technology ETF ETF Analysis | Stock Taper
Logo

XDNA

Kelly CRISPR & Gene Editing Technology ETF
Kelly CRISPR & Gene Editing Technology ETF KellyETFs
$7.38 -1.60% (-0.12)

No price data available
Managing Company KellyETFs
Asset Under Management $2.59M
Inception Date Jan 13, 2022
Expense Ratio 0.78%
52w High $11.83
52w Low $5.87
Volume 4,251
Avg Volume 5,044
Asset Class Equity

About Kelly CRISPR & Gene Editing Technology ETF

The adviser employs a “passive management” investment approach designed to track the total return performance of the index. The index is a rules-based index that consists of the stocks or corresponding depositary receipts of companies engaged in the creation, development, production, operation, provision, distribution, ownership, servicing, licensing, leasing or franchising of at least one of the...

SECTOR HOLDINGS

Healthcare Healthcare
100.00%

ASSET ALLOCATION BY REGION

Other
100.00%

Holdings (Top 20)

No holdings data available.